Abstract
Apoptosis of arterial cells induced by oxidized low–density lipoprotein (oxLDL) is thought to contribute to the progression of vascular dysfunction and atherogenesis. It is well established that diabetes mellitus is accompanied by both glycosylation and oxidation LDL, but the biological effects of these modified lipoproteins are poorly understood. We demonstrate here that glycosylated oxLDL (glc–oxLDL) promotes apoptotic signaling in human coronary smooth muscle cells. This was associated by a decrease of the antiapoptotic protein Bcl–2, an increase of the pro–apoptotic protein Bax, and activation of caspase 3. Glc–oxLDL also activated NFkB and decreased IkB, these effects were more pronounced than those achieved with oxLDL. Our study shows that glc–oxLDL influences a broad cascade of signaling transduction pathways, which may not only result in apoptosis, but also could affect NFkB in human coronary cells. This cascade of events may influence the evolution of atherogenesis and vascular complications in diabetic patients.
Similar content being viewed by others
References
Arsura M, Mercurio, F, Oliver AL, Thorgeirsson SS, Sonenshein GE (2000) Role of the I_B Kinase complex in oncogenic ras- and raf-mediated transformation of rat liver epithelial. J Biol Chem 20:5381–5391
Bjorkerud B, Bjorkerud S (1996) Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells and fibroblasts. Arterioscler Thromb Vasc Biol 16:416–424
Chandra J, Samali A, Orrenius S (2000) Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29:323–333
de Nigris F, Franconi F, Maida I, Palumbo G, Anania V, Napoli C (2000) Modulation by α- and γ-tocopherol of the signaling induced by copper oxidized LDL in human coronary smooth muscle cells. Biochem Pharmacol 59:1477–1487
Dimmeler S, Haendeler J, Galle J, Zeiher AM (1997) Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the ‘response to injury’ hypothesis. Circulation 95:1760–1763
Ho FM, Liu SH, Liau CS, Lin-Shiau SY (2000) High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH2-terminal kinase and caspase 3. Circulation 101:2618–2624
Hsu SY, Hsueh AJ (2000) Tissue-specific Bcl-2 protein partners in apoptosis: an ovarian paradigm. Physiol Rev 80:593–614
Hunt JV, Smith CCT, Wolff SP (1990) Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modi.cation by glucose. Diabetes 39:1420–1424
Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K, Nagai R, Horiuchi S, Itabe H, Takano T (2000) In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Atherosclerosis 150:343–355
Jenkins AJ, Li W, Moller K, Klein RL, Fu MX, Baynes JW, Thorpe SR, Lyons TJ (1999) Pre-enrichment of modified low density lipoproteins with alpha-tocopherol mitigates adverse effects on cultured retinal capillary cells. Curr Eye Res 19:137–145
Jovinge S, Crisby M, Thybergand J, Nilsson J (1997) DNA fragmentation and ultrastructural changes of degenerating cells in atherosclerotic lesions on smooth muscle cells exposed to oxidized LDL in vitro. Arterioscler. Thromb Vasc Biol 17:2225–2231
Kawamura M, Heinecke JW, Chait A (1994) Pathophysiological concentration of glucose promote oxidative modi.cation of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest 94:771–778
Kennedy L, Baynes JW (1984) Non enzymatic glycosylation and the chronic complications of diabetes: An overview. Diabetologia 26:93–98
Kennedy AL, Lyons TJ (1997) Glycosylation, oxidation, and lipoxidation in the development of diabetic complications. Metabolism 46 (Suppl 1):14–21
Kockx MM, Hermann AG (2000) Apoptosis in atherosclerosis: bene.cial or detrimental? Cardiovasc Res 45:736–746
Krenz M, Oldenburg O, Wimpee H, Cohen MV, Garlid KD, Critz SD, Downey JM, Benoit JN (2002) Opening of ATPsensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol 97:365–373
Lam MC, Tan KC, Lam KS (2004) Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophages. Atherosclerosis 177:313–320
Li J, Schmidt AM (1997) Characterization and functional analysis of the promoter of RAGE. J Biol Chem 272:16498–16506
Lowry OH, Rosebrough HJ, Farr AL, Randall RJ (1951) Protein measurement with the folin-phenol reagent. J Biol Chem 193:265–275
Mercurio F, Manning AM (1999) Multiple signals converging on NFkB. Curr Opin Cell Biol 11:226–232
Napoli C, D’Armiento FP, Mancini FP, Witztum JL, Palumbo G, Palinski W (1997) Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 100:2680–2690
Napoli C, Glass CK, Witztum JL, Deutsch R, D’Armiento FP, Palinski W (1999) Influence of maternal hypercholesterolemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 354:1234–1241
Napoli C, Lerman LO, de Nigris F, Loscalzo J, Ignarro LJ (2002) Glycoxidized low-density lipoprotein downregulates endothelial nitric oxide synthase in human coronary cells. J Am Coll Cardiol 40:1515–1522
Napoli C, Mancini FP, Corso G, Malorni A, Crescenzi E, Palumbo G (1997) A simple and rapid purification procedure minimizes spontaneous oxidative modifications of low density lipoprotein and lipoprotein (a). J Biochem 121:1096–1101
Napoli C, Quehenberger O, de Nigris F, Abete P, Glass CK, Palinski W (2000) Mildly oxidized low-density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J 14:1996–2007
Napoli C, Triggiani M, Palumbo G, Condorelli M, Chiariello M, Ambrosio G (1997) Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein. Basic Res Cardiol 92:96–105
Walsh K, Smith RC, Hyo-Soo K (2000) Vascular cell apoptosis in remodeling, restenosis and plaque rupture. Circ Res 87:184–188
Orchard TJ, Virella G, Forrest KY, Evans RW, Becker DJ, Lopes-Virella MF (1999) Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh epidemiology of diabetes complications study. Diabetes 48:1454–1458
Park R, Raman KG, Lee KJ, Lu Y, Ferion LS Jr, Chow WS, Stern Description, Schmidt AM (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025–1031
Podesta’ F, Romeo G, Liu H, Krajewski S, Reed JC, Gerhardinger C, Lorenzi M (2000) Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and vitro. Am J Pathol 156:1025–1031
Reid VC, Hardwick SJ, Mitchinson M (1993) Fragmentation of DNA in P388D1 macrophages exposed to oxidized low-density lipoprotein. FEBS Lett 332:218–320
Reid VC, Mitchinson MJ, Skeppe JN (1993) Cytotoxicity of oxidized lowdensity lipoprotein to mouse peritoneal macrophages: an ultrastructural study. J Pathol 171:321–328
Ryan KM, Ernst MK, Rice NR, Voudsen KH (2000) Role of NF-Kb in p53-mediated programmed cell death. Nature 404:892–897
Ruef J, Moser M, Bode C, Kubler W, Runge MS (2001) 4-hydroxynonenal induces apoptosis, NF-kappaB-activation and formation of 8-isoprostane in vascular smooth muscle cells. Basic Res Cardiol 96:143–150
Sata M, Walsh K (1998) Endothelial cell apoptosis induced by oxidized LDL is associated with the down regulation of the cellular caspase inhibitor. J Biol Chem 273:33103–33106
Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D (1995) RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45:S77–S80
Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963– 20966
Sonoki K, Iwase M, Iino K, Ichikawa K, Yoshinari M, Ohdo S, Higuchi S, Iida M (2003) Dilazep and feno.bric acid inhibit MCP-1 mRNA expression in glycoxidized LDL-stimulated human endothelial cells. Eur J Pharmacol 475:139–147
Valen G (2004) Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure. Basic Res Cardiol 99:1–7
Vlassara H, Bucala R, Stricker L (1994) Pathogenic effects of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. Lab Invest 70:138–151
Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D, Schmidt AM (1996) Receptormediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 97:238–243
Weber AA, Zucker TP, Hasse A, Bonisch D, Wittpoth M, Schror K (1998) Antimitogenic effects of vasodilatory prostaglandins in coronary artery smooth muscle cells. Basic Res Cardiol 93 (Suppl 3):54–57
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Nigris, F., Gallo, L., Sica, V. et al. Glycoxidation of low–density lipoprotein promotes multiple apoptotic pathways and NFkB activation in human coronary cells. Basic Res Cardiol 101, 101–108 (2006). https://doi.org/10.1007/s00395-005-0560-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00395-005-0560-5